BioCentury
ARTICLE | Clinical News

Genelabs regulatory update

September 9, 1996 7:00 AM UTC

GNLB received Canadian Patent No. 2,112,130 covering its Merlin assay to detect DNA binding molecules. Merlin enables the identification and characterization of small molecule organics that are used t...